Last edition
News about "Biodeal Pharmaceuticals "
Piramal Alternatives Announces Investment of INR 110 Crore in Biodeal
Piramal Alternatives has made a significant investment of INR 110 Crore in Biodeal Pharmaceuticals Ltd., a leading contract development and manufacturing company, facilitated through convertible instruments from its Performing Credit Fund.
Biodeal Pharmaceuticals | 08/04/2024 | By Aishwarya | 542
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members